Open AccessPosttransplantation Lymphoproliferative Disorder in Lung Transplant Recipients
Author(s) -
Eli Muchtar,
Mordechai R. Kramer,
Liat Vidal,
Ron Ram,
Ronit Gurion,
Yivgenia Rosenblat,
Ilana Bakal,
Ofer Shpilberg
Publication year - 2013
Publication title -
transplantation
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0b013e31829b0718
Subject(s) - medicine , lung transplantation , immunosuppression , transplantation , asymptomatic , lymphoproliferative disorders , lung , post transplant lymphoproliferative disorder , surgery , lymphoma , rituximab
Posttransplantation lymphoproliferative disorder (PTLD) is a well-recognized complication after solid-organ transplantation. Historically, most cases of PTLD among lung transplant recipients occurred within the first year from transplantation and were associated with Epstein-Barr virus (EBV) infection. However, there are increasing reports on a late-onset form of PTLD.